- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | VENUS MEDTECH-B (02500): DATE OF BOARD MEETING | 2 | HKEx | ||
| VENUS MEDTECH Aktie jetzt für 0€ handeln | |||||
| 23.07. | Venus Medtech completes enrollment in self-expanding TAVR trial | - | MassDevice | ||
| 23.07. | Venus Medtech (Hangzhou) Inc.: Venus Medtech Announces Completion of Patient Enrollment in Pivotal China Trial for Venus-PowerX, the World's First Fully Recoverable Self-Expanding Dry-Valve TAVR System | 329 | PR Newswire |
The PREVAILS study, now fully enrolled, marks a critical step toward simultaneous regulatory submissions in China and Europe for the next-generation TAVR systemHANGZHOU, China, July 23, 2026... ► Artikel lesen | |
| 23.07. | Venus Medtech (Hangzhou) Inc.: Venus Medtech gibt den Abschluss der Patientenrekrutierung für die entscheidende chinesische Studie zu Venus-PowerX bekannt - dem weltweit ersten vollständig reponierbaren, selbstexpandierenden TAVR-System mit ... | 150 | PR Newswire | Die PREVAILS-Studie, für die die Patientenrekrutierung nun abgeschlossen ist, stellt einen entscheidenden Schritt hin zu gleichzeitigen Zulassungsanträgen in China... ► Artikel lesen | |
| 06.07. | VENUS MEDTECH-B (02500): LAPSE OF THE SUBSCRIPTION AGREEMENT IN RELATION TO THE PROPOSED ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE | 1 | HKEx | ||
| 02.07. | VENUS MEDTECH-B (02500): INSIDE INFORMATION POTENTIAL SUBSCRIPTION OF NEW SHARES AND NEW CONVERTIBLE BONDS BY INTENDED INVESTORS | 2 | HKEx | ||
| 25.06. | VENUS MEDTECH-B (02500): POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING | 1 | HKEx | ||
| 03.06. | VENUS MEDTECH-B (02500): PROXY FORM FOR USE AT THE 2025 ANNUAL GENERAL MEETING | - | HKEx | ||
| 03.06. | VENUS MEDTECH-B (02500): NOTICE OF 2025 ANNUAL GENERAL MEETING | - | HKEx | ||
| 03.06. | VENUS MEDTECH-B (02500): (1) 2025 ANNUAL REPORT (2) WORK REPORT OF THE BOARD FOR 2025 (3) WORK REPORT OF THE SUPERVISORY COMMITTEE FOR 2025 (4) PROFIT ... | 3 | HKEx | ||
| 26.05. | Venus Medtech Hosts Inaugural Global Partner Summit in Paris | 458 | PR Newswire | Company highlights international growth strategy, expanding structural heart portfolio, and commercialization prioritiesPARIS, May 26, 2026 /PRNewswire/ -- Venus Medtech convened its inaugural... ► Artikel lesen | |
| 19.05. | VENUS MEDTECH-B (02500): EXCHANGE'S DISCIPLINARY ACTION AGAINST FORMER COMPANY SECRETARY OF VENUS MEDTECH (HANGZHOU) INC. (STOCK CODE: 2500) | 1 | HKEx | ||
| 15.05. | VENUS MEDTECH-B (02500): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 1 | HKEx | ||
| 15.05. | VENUS MEDTECH-B (02500): RESIGNATION OF A DIRECTOR | - | HKEx | ||
| 06.05. | VENUS MEDTECH-B (02500): CHANGE OF COMPANY SECRETARY AND AUTHORIZED REPRESENTATIVES | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT | - | HKEx | ||
| 29.04. | VENUS MEDTECH-B (02500): 2025 ANNUAL REPORT | 1 | HKEx | ||
| 31.03. | VENUS MEDTECH-B (02500): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED DECEMBER 31, 2025 | 1 | HKEx | ||
| 19.03. | VENUS MEDTECH-B (02500): DATE OF BOARD MEETING | 3 | HKEx | ||
| 17.11.25 | Venus Medtech (Hangzhou) Inc.: Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion | 723 | PR Newswire | Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting.
LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 46,600 | +0,83 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,200 | +0,98 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 49,750 | 0,00 % | Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD | ||
| LIFESTANCE HEALTH GROUP | 12,470 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 13,170 | +0,08 % | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | ||
| PROGYNY | 25,650 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,84 | -0,05 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 95,20 | +0,18 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,480 | +1,06 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| GENEDX | 87,05 | 0,00 % | GeneDx launches online exome testing for pediatric patients | ||
| ALIGNMENT HEALTHCARE | 13,165 | +0,04 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| SANARA MEDTECH | 34,430 | -0,06 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,120 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,670 | -0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |
VENUS MEDTECH HANGZHOU INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENUS MEDTECH HANGZHOU INC finden Sie auf Wallstreet Online.